Lord, Abbett & Co. LLC Emergent Bio Solutions Inc. Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$79.17 - $111.47 $27.1 Million - $38.1 Million	-341,864 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $28 Million - $46.1 Million	341,864 New	341,864 $35.3 Million
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $5.57 Million - $7.51 Million	-139,420 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $8.05 Million - $11 Million	-166,831 Reduced 54.48%	139,420 $7.04 Million
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $17 Million - $22.4 Million	306,251 New	306,251 $18.2 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.